A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson’s Disease
Condition(s):Advanced Parkinson’s DiseaseLast Updated:June 6, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Advanced Parkinson’s DiseaseLast Updated:June 6, 2022Completed
Condition(s):Parkinson’s Disease (PD)Last Updated:August 18, 2020Completed
Condition(s):SchizophreniaLast Updated:March 15, 2016Completed
Condition(s):Parkinson’s DiseaseLast Updated:September 4, 2013Completed
Condition(s):Parkinson’s DiseaseLast Updated:October 20, 2014Completed
Condition(s):Nonarteritic Anterior Ischemic Optic NeuropathyLast Updated:October 20, 2008Completed
Condition(s):Age-related Macular DegenerationLast Updated:April 5, 2019Withdrawn
Condition(s):Parkinson’s DiseaseLast Updated:February 18, 2021Completed
Condition(s):Advanced Parkinson’s DiseaseLast Updated:December 2, 2022Completed
Condition(s):Parkinson’s DiseaseLast Updated:August 14, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.